From the early roots of modern urology to today, genitourinary (GU) cancers have been an important part of the fields of urology and cancer biology. As medical science has advanced, newer clinical and basic viewpoints have impacted the thinking and practice in this important field. As such, GU oncology has been consistently seen as an area of rapid evolution both in biological understanding and clinical care. GU cancers continue to rise in incidence worldwide. Moreover, they represent a significant portion of cancer mortality in Asia and the western world. These facts have been met with some of the boldest and most important advances in cancer biology and therapy that have reshaped this field.
No takes yet. Share an insight, caveat, or question.
Posadas et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: